Large-scale testing (Phase 3)Looking for participantsNCT07517263
What this trial is testing
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 5,700